"Unusual blood clots" should be "listed as very rare side effects" of Johnson & Johnson's COVID-19 vaccine, but the vaccine's benefits outweigh its risks, the European Medicines Agency said Tuesday. The agency, after reviewing eight cases of rare blood clots among the millions of people in the United States who received the Johnson & Johnson vaccine, found a "possible link" to the rare blood clots but said the "risk of having this side effect is very low." U.S. health officials last week called for a pause of the Johnson & Johnson vaccine while they examined these rare blood clotting cases. Johnson & Johnson said it will now resume shipment of its vaccine in the European Union, Norway, and Iceland, as the U.S. pause continues.

Scroll for 5 things you
need to know now